Emergent Large Vessel Occlusion Stroke During New York City’s COVID-19 Outbreak

  • Shahram Majidi
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Johanna T. Fifi
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Travis R. Ladner
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Jacques Lara-Reyna
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Kurt A. Yaeger
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Benjamin Yim
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Neha Dangayach
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Thomas J. Oxley
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Tomoyoshi Shigematsu
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Benjamin R. Kummer
    Department of Neurology (B.R.K., L.K.S., J.W., M.G.F., M.S.D., S.T.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Laura K. Stein
    Department of Neurology (B.R.K., L.K.S., J.W., M.G.F., M.S.D., S.T.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Jesse Weinberger
    Department of Neurology (B.R.K., L.K.S., J.W., M.G.F., M.S.D., S.T.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Michael G. Fara
    Department of Neurology (B.R.K., L.K.S., J.W., M.G.F., M.S.D., S.T.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Reade De Leacy
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Mandip S. Dhamoon
    Department of Neurology (B.R.K., L.K.S., J.W., M.G.F., M.S.D., S.T.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Stanley Tuhrim
    Department of Neurology (B.R.K., L.K.S., J.W., M.G.F., M.S.D., S.T.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • J Mocco
    Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.

書誌事項

タイトル別名
  • Clinical Characteristics and Paraclinical Findings

この論文をさがす

説明

<jats:sec> <jats:title>Background and Purpose:</jats:title> <jats:p>The 2019 novel coronavirus outbreak and its associated disease (coronavirus disease 2019 [COVID-19]) have created a worldwide pandemic. Early data suggest higher rate of ischemic stroke in severe COVID-19 infection. We evaluated whether a relationship exists between emergent large vessel occlusion (ELVO) and the ongoing COVID-19 outbreak.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods:</jats:title> <jats:p>This is a retrospective, observational case series. Data were collected from all patients who presented with ELVO to the Mount Sinai Health System Hospitals across New York City during the peak 3 weeks of hospitalization and death from COVID-19. Patients’ demographic, comorbid conditions, cardiovascular risk factors, COVID-19 disease status, and clinical presentation were extracted from the electronic medical record. Comparison was made between COVID-19 positive and negative cohorts. The incidence of ELVO stroke was compared with the pre-COVID period.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p> Forty-five consecutive ELVO patients presented during the observation period. Fifty-three percent of patients tested positive for COVID-19. Total patients’ mean (±SD) age was 66 (±17). Patients with COVID-19 were significantly younger than patients without COVID-19, 59±13 versus 74±17 (odds ratio [95% CI], 0.94 [0.81–0.98]; <jats:italic>P</jats:italic> =0.004). Seventy-five percent of patients with COVID-19 were male compared with 43% of patients without COVID-19 (odds ratio [95% CI], 3.99 [1.12–14.17]; <jats:italic>P</jats:italic> =0.032). Patients with COVID-19 were less likely to be White (8% versus 38% [odds ratio (95% CI), 0.15 (0.04–0.81); <jats:italic>P</jats:italic> =0.027]). In comparison to a similar time duration before the COVID-19 outbreak, a 2-fold increase in the total number of ELVO was observed (estimate: 0.78 [95% CI, 0.47–1.08], <jats:italic>P</jats:italic> ≤0.0001). </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions:</jats:title> <jats:p>More than half of the ELVO stroke patients during the peak time of the New York City’s COVID-19 outbreak were COVID-19 positive, and those patients with COVID-19 were younger, more likely to be male, and less likely to be White. Our findings also suggest an increase in the incidence of ELVO stroke during the peak of the COVID-19 outbreak.</jats:p> </jats:sec>

収録刊行物

  • Stroke

    Stroke 51 (9), 2656-2663, 2020-09

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ